echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The anti-monopoly organization is going to die. Walgreens, the second-largest drug retailer in the United States, has taken the third place

    The anti-monopoly organization is going to die. Walgreens, the second-largest drug retailer in the United States, has taken the third place

    • Last Update: 2015-10-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: www.meihua.com October 29, 2015 according to media reports, Walgreens boots alliance, the second largest national chain drugstore in the United States, announced on Tuesday that it would acquire Rite Aid, the third largest drugstore group, in cash The acquisition, together with liabilities, involved $17.2 billion Walgreens said the price of Rite Aid per share was set at $9, a 48% premium to Monday's closing price The company estimates that the deal is likely to be completed in the second quarter of next year, benefiting from the first year's earnings, with synergies expected to exceed $1 billion Once the news came out, it directly triggered a burst of excitement in the two stocks - Walgreens rose 6%, Rite Aid shares rose 40% on the same day Considering the scale of the two sides, the anti-monopoly regulatory authorities must be busy again As mentioned above, before the deal was concluded, the U.S drug retail market ranked second in the Jianghu: Walgreens received more than 148 million prescriptions every year, and Rite Aid ranked third, but the scale was much smaller than the previous one CVS ranked first According to IBISWorld, a market research organization, the second largest retailer now has 58% of the market share in the drug administration and cosmetics business, while Walgreens and rite have 31% and 10% respectively In addition, Rite Aid, based in Pennsylvania, has about 4600 stores in 31 states and 8200 stores in Walgreens, according to the Wall Street Journal CVS has 7800 If the deal is concluded, the operators of the second and third largest drug administrations in the United States will gather together, and the competition with CVs will undoubtedly be further upgraded According to Wall Street reports, with the introduction of Affordable Care Act, there has been a wave of M & A in the field of health care in the United States, involving drug manufacturers, chain hospitals, insurance companies, etc The purpose of M & A is to reduce costs and enhance competitiveness At present, American chain drugstores are facing the pressure of rising drug cost Walgreens' acquisition of Rite Aid will effectively reduce costs In addition, Walgreens's wholesale business will benefit Rite Aid Earlier, Walgreens CEO pessina said the U.S market was ready for the next round of M & A because profits in all sectors were hit The government plays a more and more important role in controlling the expenditure of health care business, so they will definitely try their best to use their administrative power to reduce the expenditure of health care Last year, Walgreens acquired a stake in alliance boots, a European drugstore chain it has not yet owned CVs, on the other hand, is not idle Earlier this year, it bought target's drug agency business for $1.9 billion and plans to turn more than 1660 of its drug agencies into CVS brands Some people make a lot of money There must be more than two "newcomers" to be congratulated As the exclusive consultant of Walgreens, UBS, the sole agent of the transaction, has made a lot of money According to Jeffery nassof of Freeman & Co., a merger and acquisition consulting firm, the consulting fee for the deal should be $25 million, and the deal should yield another $25 million to $40 million It's not too cool to get $65 million in minutes Prior to the announcement of the deal, the bank ranked no more than 11% in the U.S M & a market share On the other hand, Citibank, the exclusive consultant of Rite Aid, has also reaped a lot However, this kind of large-scale transaction, both sides choose their own exclusive consultants, which is still quite rare nowadays.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.